Please wait



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)


SCHEDULE 13D/A 0001214659-24-001785 0001212502 XXXXXXXX LIVE 8 Common Stock, par value $0.0001 per share 09/23/2025 false 0001677077 02262M605 Alzamend Neuro, Inc. 480 Peachtree Road NE, Second Floor Suite 103 Atlanta GA 30326 MILTON C. AULT, III (949) 444-5464 c/o HYPERSCALE DATA, INC. 11411 SOUTHERN HIGHLANDS PARKWAY, SUITE 190 Las Vegas NV 89141 0001212502 N MILTON C. AULT, III a AF N X1 1843.00 507472.00 1843.00 507472.00 509315.00 N 13.3 IN Sole voting and dispositive power represents shares of Common Stock. Shared voting and dispositive power represents (i) 361,743 shares of Common Stock underlying shares of Series B Convertible Preferred Stock held by Ault Lending, LLC, (ii) 23,334 shares of Common Stock underlying currently exercisable warrants held by Ault Lending, LLC, (iii) 111,254 shares of Common Stock held by Ault Lending, LLC, (iv) 11,068 shares of Common Stock held by Ault Life Sciences, Inc., (v) 61 shares of Common Stock held by Ault Life Sciences Fund, LLC, and (vi) 12 shares of Common Stock underlying currently exercisable warrants held by Hyperscale Data, Inc. 0001333268 N WILLIAM B. HORNE a OO N X1 3518.00 0.00 3518.00 0.00 3518.00 N 0.1 IN Represents (i) 3,333 shares of Common Stock and (ii) 185 shares of Common Stock underlying stock options currently exercisable or exercisable within 60 days. 0001775938 N HENRY C.W. NISSER a OO N V7 926.00 0.00 926.00 0.00 926.00 N 0.0 IN Represents shares of Common Stock underlying stock options currently exercisable or exercisable within 60 days. 0001327261 N KENNETH S. CRAGUN a OO N X1 1111.00 0.00 1111.00 0.00 1111.00 N 0.0 IN Represents shares of Common Stock underlying stock options currently exercisable or exercisable within 60 days. 0001864317 N DAVID J. KATZOFF a PF N X1 1726.00 0.00 1726.00 0.00 1726.00 N 0.1 IN Represents (i) 615 shares of Common Stock and (ii) 1,111 shares of Common Stock underlying stock options currently exercisable or exercisable within 60 days. 0000896493 N HYPERSCALE DATA, INC. a AF N DE 0.00 496343.00 0.00 496343.00 496343.00 N 13.0 CO Represents (i) 12 shares of Common Stock underlying currently exercisable warrants held by it, (ii) 361,743 shares of Common Stock underlying shares of Series B Convertible Preferred Stock held by Ault Lending, LLC, (iii) 23,334 shares of Common Stock underlying currently exercisable warrants held by Ault Lending, LLC, and (iv) 111,254 shares of Common Stock held by Ault Lending, LLC. Y AULT LENDING, LLC a WC N CA 0.00 496331.00 0.00 496331.00 496331.00 N 13.0 OO Represents (i) 111,254 shares of Common Stock, (ii) 361,743 shares of Common Stock underlying shares of Series B Convertible Preferred Stock and (iii) 23,334 shares of Common Stock underlying currently exercisable warrants. Y AULT LIFE SCIENCES, INC. a WC N DE 0.00 11068.00 0.00 11068.00 11068.00 N 0.3 CO Y AULT LIFE SCIENCES FUND, LLC a WC N DE 0.00 61.00 0.00 61.00 61.00 N 0.0 OO Common Stock, par value $0.0001 per share Alzamend Neuro, Inc. 480 Peachtree Road NE, Second Floor Suite 103 Atlanta GA 30326 Item 3 is amended and restated in its entirety as follows: The securities of the Issuer purchased by each of Hyperscale Data, Ault Life Sciences and Ault Life Sciences Fund were purchased with working capital. The securities of the Issuer acquired by Ault Lending were acquired with working capital. The Shares purchased by Messrs. Ault, Horne and Katzoff were purchased with personal funds. The stock options owned by Messrs. Ault, Horne, Nisser, Cragun and Katzoff were awarded to them in their capacities as officers and/or directors of the Issuer. The aggregate purchase price of the warrants currently exercisable into 12 Shares owned directly by Ault Alliance is approximately $0. The aggregate purchase price of the 11,068 Shares owned directly by Ault Life Sciences is approximately $7,970. The aggregate purchase price of the 61 Shares owned directly by Ault Life Sciences Fund is approximately $123,707. The aggregate purchase price of the 111,254 Shares owned directly by Ault Lending is approximately $258,109. The aggregate purchase price of the approximate 839.24 shares of Series B convertible preferred stock (the "Series B Convertible Preferred Stock") and warrants currently exercisable (subject to beneficial ownership limitations contained therein) into 23,334 Shares owned directly by Ault Lending is approximately $839,245. The aggregate purchase price of the 1,843 Shares owned directly by Mr. Ault is approximately $1,179. The aggregate purchase price of the 3,333 Shares owned directly by Mr. Horne is approximately $14,028. The aggregate purchase price of the 615 Shares owned directly by Mr. Katzoff is approximately $53,374. Item 5(a) is hereby amended and restated in its entirety as follows: The aggregate percentage of Shares reported beneficially owned by the Reporting Person is based upon 3,439,861 Shares outstanding as of September 25, 2025, which is the total number of Shares outstanding as reported by the Issuer to the Reporting Persons. As of the date hereof, Mr. Ault may be deemed to beneficially own 509,315 Shares, consisting of (i) 1,843 Shares held directly by him, (ii) 361,743 Shares underlying shares of Series B Convertible Preferred Stock held by Ault Lending, (iii) 23,334 Shares underlying currently exercisable warrants held by Ault Lending, (iv) 111,254 Shares held by Ault Lending, (v) 11,068 Shares held by Ault Life Sciences, (vi) 61 Shares held by Ault Life Sciences Fund, and (vii) 12 Shares underlying currently exercisable warrants held by Hyperscale Data. Mr. Ault may be deemed to beneficially own the Shares beneficially owned by Hyperscale Data, Ault Life Sciences, Ault Life Sciences Fund and Ault Lending by virtue of his relationships with such entities described in Item 2. Percentage: Approximately 13.3% As of the date hereof, Mr. Horne may be deemed to beneficially own 3,518 Shares, consisting of (i) 3,333 Shares held directly by him and (ii) 185 Shares underlying stock options currently exercisable or exercisable within 60 days. Percentage: Approximately 0.1% As of the date hereof, Mr. Nisser may be deemed to beneficially own 926 Shares, consisting of Shares underlying stock options currently exercisable or exercisable within 60 days. Percentage: Approximately 0.0% As of the date hereof, Mr. Cragun may be deemed to beneficially own 1,111 Shares, consisting of Shares underlying stock options currently exercisable or exercisable within 60 days. Percentage: Approximately 0.0% As of the date hereof, Hyperscale Data may be deemed to beneficially own 496,343 Shares, consisting of (i) 12 Shares underlying currently exercisable warrants held directly by it, (ii) 361,743 Shares underlying shares of Series B Convertible Preferred Stock held by Ault Lending, (iii) 23,334 Shares underlying currently exercisable warrants held by Ault Lending, and (iv) 111,254 Shares held by Ault Lending. Hyperscale Data may be deemed to beneficially own the Shares beneficially owned by Ault Lending by virtue of its relationship with such entity described in Item 2. Percentage: Approximately 13.0% As of the date hereof, Ault Lending may be deemed to beneficially own 496,331 Shares, consisting of (i) 111,254 Shares held directly by it, (ii) 361,743 Shares underlying shares of Series B Convertible Preferred Stock held directly by it, and (iii) 23,334 Shares underlying currently exercisable warrants held directly by it. Percentage: Approximately 13.0% As of the date hereof, Ault Life Sciences may be deemed to beneficially own 11,068 Shares held directly by it. Percentage: Approximately 0.3% As of the date hereof, Ault Life Sciences Fund may be deemed to beneficially own 61 Shares held directly by it. Percentage: Approximately 0.0% Item 5(b) is hereby amended and restated in its entirety as follows: Mr. Ault: 1. Sole power to vote or direct vote: 1,843 2. Shared power to vote or direct vote: 507,472 3. Sole power to dispose or direct the disposition: 1,843 4. Shared power to dispose or direct the disposition: 507,472 Mr. Horne: 1. Sole power to vote or direct vote: 3,518 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 3,518 4. Shared power to dispose or direct the disposition: 0 Mr. Nisser: 1. Sole power to vote or direct vote: 926 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 926 4. Shared power to dispose or direct the disposition: 0 Mr. Cragun: 1. Sole power to vote or direct vote: 1,111 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 1,111 4. Shared power to dispose or direct the disposition: 0 Mr. Katzoff: 1. Sole power to vote or direct vote: 1,726 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 1,726 4. Shared power to dispose or direct the disposition: 0 Hyperscale Data: 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 496,343 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 496,343 Ault Lending: 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 496,331 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 496,331 Ault Life Sciences: 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 11,068 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 11,068 Ault Life Sciences Fund: 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 61 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 61 Item 5(c) is amended and restated in its entirety as follows: None of the Reporting Persons have engaged in any transactions in the Shares during the past 60 days except as set forth in Exhibit 1 hereto. Exhibit 1 - Transactions in the Securities of the Issuer During the Past 60 Days MILTON C. AULT, III /s/ Milton C. Ault, III Individual 09/25/2025 WILLIAM B. HORNE /s/ William B. Horne Individual 09/25/2025 HENRY C.W. NISSER /s/ Henry C. Nisser Individual 09/25/2025 KENNETH S. CRAGUN /s/ Kenneth S. Cragun Individual 09/25/2025 DAVID J. KATZOFF /s/ David J. Katzoff Individual 09/25/2025 HYPERSCALE DATA, INC. /s/ Milton C. Ault, III Executive Chairman 09/25/2025 AULT LENDING, LLC /s/ David J. Katzoff Manager 09/25/2025 AULT LIFE SCIENCES, INC. /s/ Milton C. Ault, III Chief Executive Officer 09/25/2025 AULT LIFE SCIENCES FUND, LLC /s/ Milton C. Ault, III Managing Member 09/25/2025